Imunon Inc
IMNN9.296USD
+0.796+9.37%
Horário de mercado （ET）Cotações atrasadas em 15 min
135.92MValor de mercado
PerdaP/L TTM
Mais detalhes de Imunon Inc Empresa
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit a strong immunological response. The third modality, FixPlas, concerns the application of Imunon’s DNA technology to produce universal cancer vaccines, also called tumor associated antigen cancer vaccines. The fourth modality, IndiPlas, is in the discovery phase and is focused on the development of personalized cancer vaccines, or neoepitope cancer vaccines. Its lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer.
Informações da empresa
Código da empresaIMNN
Nome da EmpresaImunon Inc
Data de listagemOct 27, 1993
CEODr. Stacy R. Lindborg, Ph.D.
Número de funcionários25
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 27
Endereço997 Lenox Dr Ste 100
CidadeLAWRENCEVILLE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal08648
Telefone16098969100
Sitehttps://imunon.com/
Código da empresaIMNN
Data de listagemOct 27, 1993
CEODr. Stacy R. Lindborg, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
4.91K
+6.62%
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
2.97K
+246.67%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
1.71K
--
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
784.00
--
Ms. Kimberly Graper
Ms. Kimberly Graper
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan Eylward
Ms. Susan Eylward
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Douglas Vincent Faller, M.D., Ph.D.
Dr. Douglas Vincent Faller, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Independent Director
Independent Director
--
--
Mr. James E. Dentzer
Mr. James E. Dentzer
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
4.91K
+6.62%
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
2.97K
+246.67%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
1.71K
--
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
784.00
--
Ms. Kimberly Graper
Ms. Kimberly Graper
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan Eylward
Ms. Susan Eylward
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 26 de jul
Atualizado em: sáb, 26 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Intracoastal Capital, L.L.C.
3.49%
Geode Capital Management, L.L.C.
0.45%
Tardugno (Michael H)
0.23%
BlackRock Institutional Trust Company, N.A.
0.18%
Le (Goff Corinne)
0.17%
Other
95.48%
Investidores
Investidores
Proporção
Intracoastal Capital, L.L.C.
3.49%
Geode Capital Management, L.L.C.
0.45%
Tardugno (Michael H)
0.23%
BlackRock Institutional Trust Company, N.A.
0.18%
Le (Goff Corinne)
0.17%
Other
95.48%
Tipos de investidores
Investidores
Proporção
Corporation
3.49%
Individual Investor
0.76%
Investment Advisor/Hedge Fund
0.69%
Investment Advisor
0.34%
Venture Capital
0.07%
Hedge Fund
0.05%
Other
94.61%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
52
134.45K
5.49%
-36.41K
2025Q1
50
565.85K
3.09%
-1.96M
2024Q4
52
608.75K
4.16%
-1.78M
2024Q3
50
1.20M
8.34%
-536.74K
2024Q2
48
484.50K
4.81%
-359.07K
2024Q1
49
447.12K
4.68%
-585.60K
2023Q4
59
755.78K
7.96%
-79.04K
2023Q3
65
452.55K
4.85%
-471.22K
2023Q2
68
440.18K
4.85%
-489.81K
2023Q1
80
515.97K
6.03%
-572.90K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Intracoastal Capital, L.L.C.
1.11M
5.22%
+1.11M
--
May 28, 2025
Geode Capital Management, L.L.C.
143.44K
0.67%
+3.93K
+2.82%
Mar 31, 2025
Tardugno (Michael H)
73.71K
0.35%
+4.57K
+6.61%
May 13, 2025
BlackRock Institutional Trust Company, N.A.
58.22K
0.27%
--
--
Mar 31, 2025
Le (Goff Corinne)
53.00K
0.25%
--
--
May 13, 2025
The Vanguard Group, Inc.
48.81K
0.23%
--
--
Mar 31, 2025
Anwer (Khursheed)
44.56K
0.21%
+31.71K
+246.67%
May 13, 2025
Lindborg (Stacy R. Ph.D.)
28.06K
0.13%
--
--
May 13, 2025
Braun (Donald P)
25.60K
0.12%
--
--
May 13, 2025
XTX Markets LLC
21.68K
0.1%
+271.00
+1.27%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Data
Tipo
Proporção
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
